Viyash Scientific Limited Shareholders Approve Director Appointments and CEO Incentive
Viyash Scientific Limited shareholders approved the appointment of Mr. Amit Jain and Mr. Abhiroop Jayanthi as directors. A one-time performance incentive for Mr. Rajaram Narayanan, Whole-time Director & CEO - Animal Health, was also approved. The resolutions passed with a requisite majority.
The appointment of directors and approval of executive incentives are important corporate actions that can impact governance and management structure.
The company successfully passed key resolutions regarding director appointments and executive incentives with shareholder approval.
Viyash Scientific Limited (formerly Sequent Scientific Limited) has announced the results of its postal ballot voting. The shareholders have approved the appointment of Mr. Amit Jain and Mr. Abhiroop Jayanthi as Non-Executive, Non-Independent Directors of the company. Additionally, the shareholders approved a one-time performance incentive for Mr. Rajaram Narayanan, Whole-time Director & CEO - Animal Health.
The resolutions were passed with the requisite majority. The e-voting period concluded on Sunday, June 28, 2026, and the resolutions are deemed to have been passed on this date. The company has submitted the voting results and the Scrutinizer's Report to the stock exchanges and has also made them available on its website.
What to do with a filing like this
Viyash Scientific Limited filed this with the NSE as a statutory disclosure, categorised under shareholder meetings. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Viyash Scientific Limited. Read the original for the full detail.